Quarterly results, guidance and margins, and the numbers companies would rather you skimmed.

West Pharmaceutical Services raised its 2026 profit and sales outlook after beating Q2 estimates. The drug-packaging supplier benefits from

IndiGo reported a ₹3.82 billion loss for the June quarter, reversing a year-ago profit, as jet fuel costs surged nearly 86% and a weaker rup

Thermo Fisher Scientific reported a strong second quarter, with revenue up 10% to $11.99 billion. The results, led by nearly 12% growth in l

Analysts now expect STOXX Europe 600 profits to rise 17.3% in Q2, the fastest pace in over three years. Energy sector earnings are forecast

Cemex raised its 2026 earnings outlook after a strong second quarter. The cement maker reported $1.02 billion in EBITDA, beating analyst est

Berenberg analysts say Talanx is on track to beat its 2026 profit target of around €2.7 billion. Strong quarterly earnings and a growing cla

Yansab reported its best quarterly profit since Q2 2022, with net income reaching SAR259 million. Higher selling prices and a 28.4% gross ma

Teck Resources beat second-quarter profit estimates as higher copper prices and nearly 25% more output boosted results. Shares jumped nearly

Roche reported a 2% drop in first-half sales to 30.36 billion Swiss francs, weighed down by weaker Vabysmo sales in the US and pricing refor

Stora Enso's Q2 adjusted operating profit of €160 million missed the €173.7 million consensus, sending shares down 11%. The company warns th

Cipla's first-quarter net profit fell 39% to 7.89 billion rupees, missing analyst estimates, as US oncology sales weakened and supply disrup

Jupiter Fund Management posted a 67% jump in first-half pre-tax profit to £50.7 million. The UK asset manager attracted £700 million in net